论文部分内容阅读
中国药品生物制品检定所于1997年组织各有关药品检验所对1996年抽验不合格的药品进行跟踪抽验,被抽验的共计81个生产单位生产的39个品种、188个批号。卫生部现将不合格药品向全国通报: 一、下列药品为劣药: 1.乳酸环丙沙星注射液:河南濮阳市第二制药厂(9612212)。 2.注射用头孢哌酮钠(先锋必):大连辉瑞制药有限公司(75835025、75835035)。 3.复方丹参片:广东永康药业股份有限公司(9705001)、深圳市同安药业有限公司(970201)、广
In 1997, China National Institute for the Control of Pharmaceutical and Biological Products organized all relevant drug testing institutes to conduct follow-up tests on unqualified drugs sampled in 1996. A total of 39 varieties and 188 batch numbers produced by a total of 81 manufacturing units were sampled. Ministry of Health is now notified of unqualified drugs to the country: First, the following drugs as inferior drugs: 1. Ciprofloxacin lactate injection: Henan Puyang Second Pharmaceutical Factory (9612212). 2. Cefoperazone sodium for injection (Pioneer will): Dalian Pfizer Pharmaceutical Co., Ltd. (75835025,75835035). 3. Compound Danshen tablets: Guangdong Yong Kang Pharmaceutical Co., Ltd. (9705001), Shenzhen Tongan Pharmaceutical Co., Ltd. (970201), Canton